According to the short activity, it could be earlier than the 29th of June because the number of shorts came down from 86K to 35K in 2 weeks ( end of April to 15th of May). On the other hand by the end of June 3 patients (?) will complete the study and IMO over 10 of them have past 6-month follow-up points. Of course, ATH can publish the 6-month results when there are enough cases and the 1-year results much later. These results are important for the market cap, but even more important for MC is that Big Pharma will be interested in ATH434 or that M Fox will give more money for the PD study. These can happen next week or next September, November or December. Interesting times.
According to the short activity, it could be earlier than the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 71906262 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 32338803 | 25 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |